title: De novo Renal Transplantation after Kaposi Sarcoma: Favorable Outcome in a Patient Receiving Sirolimus and Mycophenolate-Based Immunosuppression.
abstract: Immunosuppressive treatment increases the risk of infection and malignancy in organ transplant recipients. We report on a 42-year-old male renal transplant recipient who lost his first graft after reduction of immunosuppressive treatment due to Kaposi sarcoma and who successfully underwent a second renal transplant 10 years later. The patient's current treatment consists of low-dose prednisone, and the two antiproliferative immunosuppressants mycophenolate mofetil and rapamycin. 4.5 years after his second transplant, the serum creatinine is 1 mg/dl and the patient has no signs of recurrent disease.
authors.affiliation: Department of Urology, Charité Campus Mitte, Universitätsmedizin Berlin, Berlin.
authors.forename: F
authors.initials: F
authors.lastname: Friedersdorff
authors.forename: M
authors.initials: M
authors.lastname: Giessing
authors.forename: C
authors.initials: C
authors.lastname: Roller
authors.forename: D
authors.initials: D
authors.lastname: Baumunk
authors.forename: S
authors.initials: S
authors.lastname: Deger
authors.forename: K
authors.initials: K
authors.lastname: Budde
authors.forename: L
authors.initials: L
authors.lastname: Liefeldt
authors.forename: V
authors.initials: V
authors.lastname: Hartmann
authors.forename: T F
authors.initials: TF
authors.lastname: Fuller